(Q40551458)

21 September 2017

title

Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned (English)

1 reference

21 September 2017

1 reference

Jerard Seghatchian

1

1 reference

21 September 2017

publication date

1 October 2003

1 reference

Transfusion and Apheresis Science

21 September 2017

published in

1 reference

21 September 2017

volume

29

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

105-117

1 reference

Red cell storage lesion assessed by the levels of potassium, haemoglobin and Annexin V in supernatants

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Changes in haematological parameters following captive bolt stunning in relation to the increased level of Syntaxin 1-B, a CNS marker in blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Persistence of HTLV-I in blood components after leukocyte depletion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Development of a microplate method for the measurement of plasma haemoglobin and its use in monitoring the storage lesion of red cell components

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

A platelet quality assessment scheme for comparing the performance of quality monitoring laboratories in the UK National Blood Service.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

A national quality assessment scheme for counting residual leucocytes in unfixed leucodepleted products: the effect of standardisation and 48 hour storage.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Validation of different enrichment strategies for analysis of leucocyte sub-populations: development and application of a new approach, based on leucofiltration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Studies on the characterisation of the cause of leucoreduction failures, with particular reference to extra gatal events

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Cytokines as quality indicators of leucoreduced red cell concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

The quality of MCS+ version C2 double dose platelet concentrate with leucodepletion through a continuous filtration process

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

What's happening? The quality of methylene blue treated FFP and cryo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Prioritizing the options for enhancing blood component safety

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Continuous improvements in national leucodepletion outcome and potential cause of leucodepletion failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Transfusion medicine in Norway 2001. Time for change

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Current strategies on pathogen removal/inactivation: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Current strategies for the provision of safer plasma and its derivatives: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

The effects of leucocyte depletion on the generation and removal of microvesicles and prion related protein in blood components

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Blood component safety

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Changes in patterns of bradykinin generation during leucocyte filtration of platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Residual red cell and platelet content in WBC-reduced plasma measured by a novel flow cytometric method

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Effect of processing and storage on platelet activation, cellular injury and microvesiculation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Monitoring universal leucodepletion performance: the current issues within components production and testing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

New developments in blood components: focus on improved safety of blood components through process modification

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Bacterial contamination of blood components

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Platelet storage lesion and apoptosis: are they related?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Leukoreduction of sickle cell trait blood: an unresolved issue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

A case of leucodepletion failure in Cobe spectra plateletpheresis: further studies on the identification of the potential cause

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Studies on the improvement of leucodepletion performance of the Haemonetics MCS+ for production of leucodepleted platelet concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

The effect of leucocyte depletion on the quality of fresh-frozen plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Statistical process monitoring of WBC-reduced blood components assessed by two types of software

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Counting of residual WBCs in WBC-reduced blood components: a multicenter evaluation of a microvolume fluorimeter by the United Kingdom National Blood Service

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Leucodepletion process performance variation: is it dependent on the batch of filters, the processing centre or the counting technology?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Editorial: focus on quality assurance research development

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

UK strategy for process qualification/validation: from concept to practical implementation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

The role of in process qualification in quality improvement of the haemonetics MCS plus leucodepleted platelet concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Pharmacological therapies to minimise platelet transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Does bacterial contamination of platelet concentrates influence the leucocyte content and the rate of platelet storage lesion?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Factors influencing the outcome of leucodepletion system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Current position on preparation and quality of leucodepleted platelet concentrates for clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Leucocyte fragments in 'prestorage-leucodepleted' blood products: a qualitative analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

National evaluation of IMAGN 2000 for quality monitoring of leucodepleted red cell and platelet concentrates: comparison with flow and Nageotte.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Leucofiltration, retention/generation of soluble prion and annexin V and storage of blood components

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Leucofiltration of sickle cell trait blood "the blocker": NBS London & S.E. experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

nvCJD and leucodepletion: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characteristics of the red cell and platelet concentrates and the clinical responses to transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Laboratory and clinical aspects of platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

The Second International Forum on variant CJD and leucodepletion: UK

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

The UK strategy for monitoring universal leucodepletion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Establishment of new national proficiency testing schemes for leucodepleted blood components: UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Annexin V and platelet antigen expression is not altered during storage of platelet concentrates obtained with the AMICUS cell separator

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Preparation and storage characteristics of white cell-reduced high-concentration platelet concentrates collected by anapheresis system for transfusions in utero

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

Quality monitoring of platelet concentrates: the need for standardization/harmonization of cellular content and assessment of platelet functional reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900112-5

7 January 2021

10.1016/S1473-0502(03)00112-5

Identifiers

DOI

1 reference

21 September 2017

1 reference